Cargando…
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
Burkholderia pseudomallei is the causative agent of melioidosis, a serious disease endemic in Southeast Asia and Northern Australia. Antibiotic treatment is lengthy and relapse often occurs. Finafloxacin is a novel fluoroquinolone with increased antibacterial activity in acidic conditions in contras...
Autores principales: | Barnes, Kay B., Hamblin, Karleigh A., Richards, Mark I., Laws, Thomas R., Vente, Andreas, Atkins, Helen S., Harding, Sarah V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487660/ https://www.ncbi.nlm.nih.gov/pubmed/28438936 http://dx.doi.org/10.1128/AAC.00082-17 |
Ejemplares similares
-
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4
por: Barnes, Kay B., et al.
Publicado: (2019) -
Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection
por: Barnes, Kay B., et al.
Publicado: (2021) -
Efficacy of finafloxacin in a murine model of inhalational glanders
por: Barnes, Kay B., et al.
Publicado: (2022) -
Demonstration of the Broad-Spectrum In Vitro Activity of Finafloxacin against Pathogens of Biodefense Interest
por: Barnes, Kay B., et al.
Publicado: (2019) -
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever
por: Hartley, M. Gill, et al.
Publicado: (2021)